466 related articles for article (PubMed ID: 16467860)
1. Sustained expression after nonviral ocular gene transfer using mammalian promoters.
Kachi S; Esumi N; Zack DJ; Campochiaro PA
Gene Ther; 2006 May; 13(9):798-804. PubMed ID: 16467860
[TBL] [Abstract][Full Text] [Related]
2. Nonviral ocular gene transfer.
Kachi S; Oshima Y; Esumi N; Kachi M; Rogers B; Zack DJ; Campochiaro PA
Gene Ther; 2005 May; 12(10):843-51. PubMed ID: 15789063
[TBL] [Abstract][Full Text] [Related]
3. CMV enhancer/human PDGF-beta promoter for neuron-specific transgene expression.
Liu BH; Wang X; Ma YX; Wang S
Gene Ther; 2004 Jan; 11(1):52-60. PubMed ID: 14681697
[TBL] [Abstract][Full Text] [Related]
4. Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter.
Gill DR; Smyth SE; Goddard CA; Pringle IA; Higgins CF; Colledge WH; Hyde SC
Gene Ther; 2001 Oct; 8(20):1539-46. PubMed ID: 11704814
[TBL] [Abstract][Full Text] [Related]
5. In vivo electroporation and ubiquitin promoter--a protocol for sustained gene expression in the lung.
Gazdhar A; Bilici M; Pierog J; Ayuni EL; Gugger M; Wetterwald A; Cecchini M; Schmid RA
J Gene Med; 2006 Jul; 8(7):910-8. PubMed ID: 16685743
[TBL] [Abstract][Full Text] [Related]
6. Increased level and duration of expression in muscle by co-expression of a transactivator using plasmid systems.
Li S; MacLaughlin FC; Fewell JG; Li Y; Mehta V; French MF; Nordstrom JL; Coleman M; Belagali NS; Schwartz RJ; Smith LC
Gene Ther; 1999 Dec; 6(12):2005-11. PubMed ID: 10637452
[TBL] [Abstract][Full Text] [Related]
7. Time course of gene expression after plasmid DNA gene transfer to the liver.
Herweijer H; Zhang G; Subbotin VM; Budker V; Williams P; Wolff JA
J Gene Med; 2001; 3(3):280-91. PubMed ID: 11437333
[TBL] [Abstract][Full Text] [Related]
8. High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter.
Yew NS; Przybylska M; Ziegler RJ; Liu D; Cheng SH
Mol Ther; 2001 Jul; 4(1):75-82. PubMed ID: 11472109
[TBL] [Abstract][Full Text] [Related]
9. Gene delivery and expression in human retinal pigment epithelial cells: effects of synthetic carriers, serum, extracellular matrix and viral promoters.
Urtti A; Polansky J; Lui GM; Szoka FC
J Drug Target; 2000; 7(6):413-21. PubMed ID: 10758912
[TBL] [Abstract][Full Text] [Related]
10. Cre-loxP system as a versatile tool for conferring increased levels of tissue-specific gene expression from a weak promoter.
Nakamura S; Watanabe S; Ohtsuka M; Maehara T; Ishihara M; Yokomine T; Sato M
Mol Reprod Dev; 2008 Jun; 75(6):1085-93. PubMed ID: 18163444
[TBL] [Abstract][Full Text] [Related]
11. A novel nonviral cytoplasmic gene expression system and its implications in cancer gene therapy.
Chen X; Li Y; Xiong K; Xie Y; Aizicovici S; Snodgrass R; Wagner TE; Platika D
Cancer Gene Ther; 1995 Dec; 2(4):281-9. PubMed ID: 8548582
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of VEGF in retinal pigmented epithelial cells is not sufficient to cause choroidal neovascularization.
Oshima Y; Oshima S; Nambu H; Kachi S; Hackett SF; Melia M; Kaleko M; Connelly S; Esumi N; Zack DJ; Campochiaro PA
J Cell Physiol; 2004 Dec; 201(3):393-400. PubMed ID: 15389527
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of viral and mammalian promoters for driving transgene expression in mouse liver.
Al-Dosari M; Zhang G; Knapp JE; Liu D
Biochem Biophys Res Commun; 2006 Jan; 339(2):673-8. PubMed ID: 16316630
[TBL] [Abstract][Full Text] [Related]
14. Electroporation enhances reporter gene expression following delivery of naked plasmid DNA to the lung.
Pringle IA; McLachlan G; Collie DD; Sumner-Jones SG; Lawton AE; Tennant P; Baker A; Gordon C; Blundell R; Varathalingam A; Davies LA; Schmid RA; Cheng SH; Porteous DJ; Gill DR; Hyde SC
J Gene Med; 2007 May; 9(5):369-80. PubMed ID: 17410613
[TBL] [Abstract][Full Text] [Related]
15. Organ-specific gene expression in the rhesus monkey eye following intravenous non-viral gene transfer.
Zhang Y; Schlachetzki F; Li JY; Boado RJ; Pardridge WM
Mol Vis; 2003 Oct; 9():465-72. PubMed ID: 14551536
[TBL] [Abstract][Full Text] [Related]
16. Sustained, high transgene expression in liver with plasmid vectors using optimized promoter-enhancer combinations.
Magnusson T; Haase R; Schleef M; Wagner E; Ogris M
J Gene Med; 2011 Jul; 13(7-8):382-91. PubMed ID: 21721074
[TBL] [Abstract][Full Text] [Related]
17. Comparison of promoter region constructs for in vivo intramuscular expression.
Fabre EE; Bigey P; Orsini C; Scherman D
J Gene Med; 2006 May; 8(5):636-45. PubMed ID: 16477670
[TBL] [Abstract][Full Text] [Related]
18. Construction of modular and versatile plasmid vectors for the high-level expression of single or multiple genes in insects and insect cell lines.
Huynh CQ; Zieler H
J Mol Biol; 1999 Apr; 288(1):13-20. PubMed ID: 10329122
[TBL] [Abstract][Full Text] [Related]
19. Cloning and molecular dissection of the 8.8 kb pig uroplakin II promoter using transgenic mice and RT4 cells.
Kwon DN; Choi YJ; Park JY; Cho SK; Kim MO; Lee HT; Kim JH
J Cell Biochem; 2006 Oct; 99(2):462-77. PubMed ID: 16619260
[TBL] [Abstract][Full Text] [Related]
20. A Renilla luciferase-Aequorea GFP (ruc-gfp) fusion gene construct permits real-time detection of promoter activation by exogenously administered mifepristone in vivo.
Yu YA; Szalay AA
Mol Genet Genomics; 2002 Oct; 268(2):169-78. PubMed ID: 12395191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
